Denver Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,274
Closed -$304K 486
2017
Q1
$304K Sell
1,274
-1,933
-60% -$450K 0.01% 391
2016
Q4
$673K Sell
3,207
-3,431
-52% -$711K 0.03% 297
2016
Q3
$1.53M Buy
6,638
+4,761
+254% +$1.16M 0.07% 217
2016
Q2
$434K Sell
1,877
-14
-0.7% -$3.23K 0.02% 347
2016
Q1
$507K Sell
1,891
-6
-0.3% -$1.72K 0.02% 330
2015
Q4
$593K Sell
1,897
-11,009
-85% -$3.28M 0.03% 334
2015
Q3
$3.51M Buy
12,906
+1,307
+11% +$401K 0.15% 158
2015
Q2
$3.52M Sell
11,599
-3,170
-21% -$945K 0.13% 164
2015
Q1
$4.4M Sell
14,769
-2,731
-16% -$779K 0.14% 168
2014
Q4
$4.5M Buy
17,500
+1,383
+9% +$346K 0.14% 160
2014
Q3
$3.89M Sell
16,117
-8,997
-36% -$2.01M 0.13% 182
2014
Q2
$5.6M Sell
25,114
-2,861
-10% -$592K 0.17% 148
2014
Q1
$5.76M Sell
27,975
-5
-0% -$990 0.17% 168
2013
Q4
$4.7K Buy
+27,980
New +$4.37M 0.13% 200

Other funds holding AGN

Denver Investment Advisors's AGN Position: Q2 2017 in Review

Denver Investment Advisors sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 1,274 shares — an estimated $304K sold.

Denver Investment Advisors first reported a position in AGN in Q4 2013 and held it in 14 quarters. The position peaked at $5.76M in Q1 2014. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Denver Investment Advisors reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Denver Investment Advisors sold 1,274 Allergan plc shares in Q2 2017, an estimated $304K.
  • Denver Investment Advisors first reported a position in Allergan plc in Q4 2013 and held it in 14 quarters.
  • Denver Investment Advisors's Allergan plc position peaked at $5.76M in Q1 2014.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Denver Investment Advisors's 13F filing for Q2 2017, filed 3 Aug 2017.